Clinical Trials Data Marijuana Media 
CannaMD
NOVEMBER 6, 2019
Marijuana has long been used for pain in medical traditions around the world. Today, both patient experience and modern scientific research support claims of medical marijuana’s effectiveness for pain management. It is also known that marijuana targets the body’s pain receptors in ways similar to synthetic opioids.
Cannabis Law Report
NOVEMBER 22, 2019
MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. Tim Moynahan the company chairman stated that “Patients in the MMJ International holdings clinical trials will receiv e gelatin capsules containing THC and CBD daily.”.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JULY 9, 2021
Clinical trials involving psychedelic drugs and substances are, however, permitted, provided they comply with both state and federal laws applicable to such trials. states that have legalized marijuana for therapeutic or adult-use, which is currently illegal under U.S. federal law. Related Links.
Miss Marijuana
JUNE 30, 2019
I mean duh, with social media, bosses that don’t understand you have a life and the new Bob Dylan documentary on Netflix – how can anyone doze off and dream anymore? Miss Marijuana will break it down for you Bill Nye style so you can get back to your regularly scheduled program or go buy some CBD products! .
Weedistry
JANUARY 28, 2019
The data also indicate that fentanyl and other fentanyl-related substances continue to be a major driver of this crisis,” Health Canadanotes. It’s when presented with personal stories like that of the Rhodes family and the stream of alarming data that the significance of Tetra Bio-Pharma’s (TBP) clinical trials is worth exploring.
The Blunt Truth
AUGUST 13, 2019
To understand the breadth of issues and gather data on safety we have conducted a public hearing, reviewed the medical literature, and have an open public docket.”. The FDA is collecting data to fill these gaps. The FDA cautioned that, without prompt action, legal action may follow, including seizure and injunctions.
The Joint Blog
JULY 25, 2020
Lately, CBD has warranted a huge share of public and media attention for its perceived benefits to health and well-being. The agency maintains that they need more time to probe further into the science of cannabidiol, which will require thorough research and clinical trials before they can conclude certain products as GRAS. “To
Expert insights. Personalized for you.
87 
Let's personalize your content